The OASIS (Overall Anxiety Severity and Impairment Scale) is a brief, 5-item transdiagnostic measure designed to assess the frequency and intensity of anxiety, as well as the level of functional impairment it causes in daily life. Unlike disorder-specific tools, the OASIS works across all anxiety presentations—including social anxiety, panic, and phobias—making it an essential component of Measurement-Based Care (MBC) for complex clinical cases.

• The Advantage: It captures how anxiety interferes with work, school, and relationships, providing a broader view of the client’s quality of life.
• The Workflow: Because it is only five questions, it is ideal for session-by-session monitoring without causing “survey fatigue.”

The OASIS measures five key dimensions of anxiety: frequency of symptoms, intensity of symptoms, behavioral avoidance, and impairment in work/school and social functioning. By focusing on these core areas, the OASIS helps clinicians determine if a client’s anxiety is truly improving or if they are simply experiencing fewer symptoms while still being significantly impaired in their daily activities.

The OASIS is scored by rating each of the five items on a scale of 0 to 4, resulting in a total score between 0 and 20. Higher scores reflect greater anxiety severity and higher levels of life impairment.

• Score Interpretation: Clinicians look for a “downward trajectory” in scores over time. A decreasing score on the OASIS is a strong indicator that the therapeutic intervention is effectively restoring the client’s ability to function in their social and professional life.

A total score of 8 or higher on the OASIS is the most commonly recognized clinical cutoff, suggesting that the client’s anxiety is likely clinically significant and requires intervention. While some research suggests a threshold as low as 7.5 in specific populations, a score of 8 serves as a robust “red flag” for clinicians to conduct a more detailed diagnostic assessment.

No, the OASIS is a screening and progress-monitoring tool, not a diagnostic instrument for specific conditions like OCD or GAD. Its primary role is to provide a “provisional” view of overall anxiety severity. A formal diagnosis still requires a comprehensive clinical interview and professional judgment to differentiate between various anxiety-related conditions.

The GAD-7 is designed specifically to screen for Generalized Anxiety Disorder, whereas the OASIS is “transdiagnostic,” meaning it measures anxiety symptoms regardless of the specific diagnosis. * When to use GAD-7: When the primary clinical focus is on uncontrollable worry and generalized symptoms.

• When to use OASIS: When the clinician needs to track how anxiety—of any type—is causing avoidance behaviors and interfering with the client’s ability to function in the world.

Yes, the OASIS is a rigorously validated, evidence-based measure with high internal consistency and strong psychometric properties across diverse clinical settings. It is frequently cited in psychological research for its “high clinical utility,” as it provides reliable data with minimal administrative burden for both the clinician and the client.

Digital OASIS tracking via MyOutcomes automates the scoring process and generates instant visual trend lines that highlight the relationship between anxiety levels and functional improvement. By using a digital dashboard, therapists can immediately see if a client’s “Avoidance” score is dropping, which is often a lead indicator of successful trauma or anxiety treatment before the total symptom count begins to decrease.